Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Adriana T. Moreno"'
Autor:
Maria Leonor S Oliveira, Eliane N Miyaji, Daniela M Ferreira, Adriana T Moreno, Patricia C D Ferreira, Fernanda A Lima, Fernanda L Santos, Maria Aparecida Sakauchi, Célia S Takata, Hisako G Higashi, Isaías Raw, Flavia S Kubrusly, Paulo L Ho
Publikováno v:
PLoS ONE, Vol 5, Iss 5, p e10863 (2010)
Streptococcus pneumoniae is the leading cause of respiratory acute infections around the world. In Latin America, approximately 20,000 children under 5 years of age die of pneumococcal diseases annually. Pneumococcal surface protein A (PspA) is among
Externí odkaz:
https://doaj.org/article/1b946053c3cd4f4188038c4cc3e3bbba
Autor:
Maria Leonor S. Oliveira, David E. Briles, Daniela M. Ferreira, Eliane N. Miyaji, Stephen B. Gordon, Paulo Lee Ho, Adriana T. Moreno, Cintia F. M. Vadesilho
Publikováno v:
Clinical and Vaccine Immunology. 21:940-948
Pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC) are important candidates for an alternative vaccine against pneumococcal infections. Since these antigens show variability, the use of variants that do not afford broad p
Autor:
Daniela M. Ferreira, Eliane N. Miyaji, Patricia C. D. Ferreira, Jorge Ferreira, Paulo Lee Ho, Giovana M. P. Palma, Fernanda A. Lima, Maria Leonor S. Oliveira, Adriana T. Moreno, Isaias Raw
Publikováno v:
Clinical and Vaccine Immunology. 19:1382-1392
Streptococcus pneumoniae is a pathogen of great importance worldwide. We have previously described the efficacy of a nasal vaccine composed of the pneumococcal surface protein A and the whole-cell pertussis vaccine as an adjuvant against a pneumococc
Autor:
Giovana M. P. Palma, Cintia F. M. Vadesilho, Maria Leonor S. Oliveira, Silvia Regina Cavani Jorge Santos, Daniela M. Ferreira, Eliane N. Miyaji, Adriana T. Moreno, Marina Baquerizo Martinez, Paulo Lee Ho, Jorge Ferreira
Publikováno v:
Clinical and Vaccine Immunology. 19:499-507
Pneumococcal surface protein C (PspC) is an important candidate for a cost-effective vaccine with broad coverage against pneumococcal diseases. Previous studies have shown thatStreptococcus pneumoniaeis able to bind to both human factor H (FH), an in
Autor:
Daniela M. Ferreira, Aurora Marques Cianciarullo, Eliane N. Miyaji, Adriana T. Moreno, Maria Leonor S. Oliveira, Paulo Lee Ho
Publikováno v:
Microbial Pathogenesis. 47:157-163
The differences between the immune response elicited during a self-limiting and a life-threatening lung infection with Streptococcus pneumoniae was analyzed in a mouse model of intranasal challenge using two different pneumococcal strains. M10, a ser
Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades
Autor:
Michelle Darrieux, Luciana C. C. Leite, Fabiana Cristina Pimenta, Ana Lucia Andrade, Daniela M. Ferreira, Adriana T. Moreno, Eliane N. Miyaji, Alexandre P. Y. Lopes
Publikováno v:
Journal of Medical Microbiology. 57:273-278
Pneumococcal surface protein A (PspA) is an important vaccine candidate against pneumococcal infections, capable of inducing protection in different animal models. Based on its structural diversity, it has been suggested that a PspA-based vaccine sho
Autor:
Daniela M, Ferreira, Daniel R, Neill, Mathieu, Bangert, Jenna F, Gritzfeld, Nicola, Green, Adam K A, Wright, Shaun H, Pennington, Laura, Bricio-Moreno, Laura, Bricio Moreno, Adriana T, Moreno, Eliane N, Miyaji, Angela D, Wright, Andrea M, Collins, David, Goldblatt, Aras, Kadioglu, Stephen B, Gordon
Publikováno v:
American journal of respiratory and critical care medicine. 187(8)
The immunological and protective role of pneumococcal carriage in healthy adults is not known, but high rates of disease and death in the elderly are associated with low carriage prevalence.We employed an experimental human pneumococcal carriage mode
Autor:
Adriana T. Moreno, Daniela M. Ferreira, Cintia F. M. Vadesilho, Eliane N. Miyaji, Paulo Lee Ho, Carlos Chávez-Olórtegui, Ricardo Andrez Machado De Ávila, Maria Leonor S. Oliveira
Publikováno v:
Microbial pathogenesis. 53(5-6)
Pneumococcal surface protein A (PspA) is an important candidate for a vaccine against pneumococcal infections. DNA vaccines expressing PspA were shown to protect mice against intraperitoneal and colonization challenge models in mice. We now show that
Autor:
Adriana T. Moreno, M.L. Sarno de Oliveira, Daniela M. Ferreira, Eliane N. Miyaji, Paulo Lee Ho, Patricia C. D. Ferreira
Publikováno v:
International Journal of Infectious Diseases. 14
Autor:
Maria Leonor S. Oliveira, Luciana C. C. Leite, Paulo Lee Ho, Ana Lucia Andrade, Jorge Ferreira, Fabiana Cristina Pimenta, Adriana T. Moreno, Michelle Darrieux, Daniela M. Ferreira, Eliane N. Miyaji
Publikováno v:
Clinical and vaccine immunology : CVI. 17(3)
PspA is an important candidate for a vaccine with serotype-independent immunity against pneumococcal infections. Based on sequence relatedness, PspA has been classified into three families comprising six clades. We have previously addressed the cross